Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
apremilast (CC-10004)
print preview
bookmark
share with colleague
General Information
Company
Celgene Corp.
Description
Oral phosphodiesterase-4 (PDE-4) inhibitor
Molecular Target
Phosphodiesterase-4 (PDE-4)
;
Interleukin-2 (IL-2)
Mechanism of Action
Phosphodiesterase-4 (PDE-4) inhibitor; Tumor necrosis factor (TNF) alpha inhibitor; Nitric oxide (NO) synthase inhibitor
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Disease Category
Standard Indication
Indication Details
Partners
Milestones
Latest Stage of Development
More
Archive Items are loading
Set Email Alert
dummy